Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...
Prostate cancer is the most common cancer in men in the United States aside from skin cancer. Dr. Jose Avitia, a medical oncologist with the New Mexico Cancer Center talked about prostate cancer and ...
Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, ...
At the American Urological Association annual meeting, several studies explored the potential role of surgery in managing metastatic prostate cancer. In this exclusive MedPage Today video, Jeremy ...
Morning Overview on MSN
Study maps prostate immune niches, finds T cells linger for months
Prostate cancer has long frustrated immunologists. Checkpoint inhibitors that unleash the immune system against tumors in the ...
NEW HAVEN, Conn. (WTNH) — Understanding prostate cancer and the role genetics play can be very important for your health. With one in nine men affected by this disease, scientists at Hartford ...
From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...
TTUHSC researcher Srinivas Nandana, Ph.D., (left) and co-investigator Manisha Tripathi, Ph.D., received a grant from the U.S. Department of Defense to investigate the role of TBX2 in establishing the ...
Prostate cancer is the most common cancer in men, and genetic variants in DNA damage repair and response genes are known to have a role in disease progression. For example, men with inherited or ...
A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results